KR20160090262A - Hetero-cyclic compound and organic light emitting device comprising the same - Google Patents

Abstract

The present invention relates to a heterocyclic compound and an organic light-emitting device comprising the same. The compound is represented by chemical formula 1. According to an embodiment of the present invention, the heterocyclic compound can be used as a material of an organic matter layer of an organic light-emitting device.

Description

[0001] HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME [0002]

The present application claims the benefit of Korean Patent Application No. 10-2015-0010158, filed on January 21, 2015, to the Korean Intellectual Property Office, the entire contents of which are incorporated herein by reference.

TECHNICAL FIELD The present invention relates to heterocyclic compounds and organic light emitting devices comprising the same.

In general, organic light emission phenomenon refers to a phenomenon in which an organic material is used to convert electric energy into light energy. An organic light emitting device using an organic light emitting phenomenon generally has a structure including an anode, a cathode, and an organic material layer therebetween. Here, in order to increase the efficiency and stability of the organic light emitting device, the organic material layer may have a multi-layer structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic light emitting device, holes are injected in the anode, electrons are injected into the organic layer in the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out.

Development of new materials for such organic light emitting devices has been continuously required.

International Patent Application Publication No. 2003-012890

The present invention provides a heterocyclic compound and an organic light emitting device including the heterocyclic compound.

The present invention provides a heterocyclic compound represented by the following general formula (1).

[Chemical Formula 1]

In Formula 1,

Ar ₁ and Ar ₂ are the same or different and each independently represent a substituted or unsubstituted aryl group having 6 to 30 carbon atoms,

Ar ₃ is a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms,

L ₁ and L ₂ are the same or different and are each independently a direct bond; A substituted or unsubstituted arylene group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic heteroarylene group having 2 to 30 carbon atoms,

n is 1 or 2,

When n is 2, Ar ₃ is the same as or different from each other.

A first electrode; A second electrode facing the first electrode; And at least one organic compound layer disposed between the first electrode and the second electrode, wherein at least one of the organic compound layers includes a heterocyclic compound represented by Formula 1 An organic light emitting device is provided.

The heterocyclic compound according to one embodiment of the present invention can be used as a material of an organic material layer of an organic light emitting device and by using it, it is possible to improve the efficiency, the driving voltage and / or the lifetime characteristics of the organic light emitting device.

1 shows an organic light emitting device 10 according to an embodiment of the present invention.
2 shows an organic light emitting element 11 according to another embodiment of the present invention.
3 shows MS data of the compound 1-1 prepared by Synthesis Example 1. FIG.

Hereinafter, the present specification will be described in detail.

The present invention provides a heterocyclic compound represented by the above formula (1).

In this specification, when a part is referred to as "including " an element, it is to be understood that it may include other elements as well, without departing from the other elements unless specifically stated otherwise.

In this specification, when a member is located on another member, it includes not only the case where the member is in contact with the other member but also the case where another member exists between the two members.

As used herein, the term "adjacent" means that the substituent is a substituent substituted on an atom directly connected to the substituted atom, a substituent stereostructically closest to the substituent, or another substituent substituted on the substituted atom . For example, two substituents substituted in the benzene ring to the ortho position and two substituents substituted on the same carbon in the aliphatic ring may be interpreted as "adjacent" groups to each other.

Examples of substituents in the present specification are described below, but are not limited thereto.

The term "substituted" means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the substituted position is not limited as long as the substituent is a substitutable position, , Two or more substituents may be the same as or different from each other.

As used herein, the term " substituted or unsubstituted " A halogen group; A nitrile group; A nitro group; Imide; Amide group; Carbonyl group; An ester group; A hydroxy group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted aryloxy group; A substituted or unsubstituted alkylthio group; A substituted or unsubstituted arylthio group; A substituted or unsubstituted alkylsulfoxy group; A substituted or unsubstituted arylsulfoxy group; A substituted or unsubstituted alkenyl group; A substituted or unsubstituted silyl group; A substituted or unsubstituted boron group; A substituted or unsubstituted amine group; A substituted or unsubstituted arylphosphine group; A substituted or unsubstituted phosphine oxide group; A substituted or unsubstituted aryl group; And a substituted or unsubstituted heterocyclic group, or that at least two of the substituents exemplified above are substituted with a substituent to which they are linked, or have no substituent. For example, "a substituent to which at least two substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group, and may be interpreted as a substituent in which two phenyl groups are connected.

는 다른 치환기 또는 결합부에 결합되는 부위를 의미한다.In the present specification,

Quot; refers to a moiety bonded to another substituent or bond.

In the present specification, the halogen group may be fluorine, chlorine, bromine or iodine.

In the present specification, the number of carbon atoms in the imide group is not particularly limited, but is preferably 1 to 30 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.

In the present specification, the amide group may be substituted with nitrogen of the amide group by hydrogen, a straight chain, branched chain or cyclic alkyl group of 1 to 30 carbon atoms or an aryl group of 6 to 30 carbon atoms. Specifically, it may be a compound of the following structural formula, but is not limited thereto.

In the present specification, the carbon number of the carbonyl group is not particularly limited, but is preferably 1 to 30 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.

In the present specification, the ester group may be substituted with an ester group oxygen in a straight chain, branched chain or cyclic alkyl group having 1 to 25 carbon atoms or an aryl group having 6 to 30 carbon atoms. Specifically, it may be a compound of the following structural formula, but is not limited thereto.

In the present specification, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec- N-pentyl, 3-dimethylbutyl, 2-ethylbutyl, heptyl, n-hexyl, Cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethyl Heptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl and the like.

In the present specification, the cycloalkyl group is not particularly limited, but is preferably a group having 3 to 30 carbon atoms. Specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, But are not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, isobutyl, sec-butyl, It is not.

In the present specification, the alkoxy group may be linear, branched or cyclic. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably 1 to 30 carbon atoms. Specific examples include methoxy, ethoxy, n-propoxy, isopropoxy, i-propyloxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentyloxy, neopentyloxy, N-hexyloxy, n-hexyloxy, 3,3-dimethylbutyloxy, 2-ethylbutyloxy, n-octyloxy, n-nonyloxy, n-decyloxy, benzyloxy, But is not limited thereto.

In this specification, the amine group is -NH ₂ ; An alkylamine group; N-arylalkylamine groups; An arylamine group; An N-arylheteroarylamine group; An N-alkylheteroarylamine group, and a heteroarylamine group, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30. Specific examples of the amine group include methylamine, dimethylamine, ethylamine, diethylamine, phenylamine, naphthylamine, biphenylamine, anthracenylamine, 9-methyl- , A diphenylamine group, an N-phenylnaphthylamine group, a ditolylamine group, an N-phenyltolylamine group, and a triphenylamine group, but are not limited thereto.

In the present specification, the N-alkylarylamine amine group means an amine group in which N in the amine group is substituted with an alkyl group and an aryl group.

In the present specification, the N-arylheteroarylamine group means an amine group in which N in the amine group is substituted with an aryl group and a heteroaryl group.

In the present specification, the N-alkylheteroarylamine group means an amine group in which N in the amine group is substituted with an alkyl group and a heteroarylamine group.

In the present specification, the alkyl group in the alkylamine group, the N-arylalkylamine group, the alkylthio group, the alkylsulfoxy group and the N-alkylheteroarylamine group is the same as the alkyl group described above. Specific examples of the alkyloxy group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group and an octylthio group. Examples of the alkylsulfoxy group include a mesyl group, an ethylsulfoxy group, a propylsulfoxy group, And the like, but the present invention is not limited thereto.

In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 30. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, Butenyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, (Diphenyl-1-yl) vinyl-1-yl, stilbenyl, stilenyl, and the like.

In the present specification, the silyl group specifically includes a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, However, the present invention is not limited thereto.

In the present specification, the boron group may be -BR ₁₀₀ R ₁₀₁ , wherein R ₁₀₀ and R ₁₀₁ are the same or different and each independently hydrogen; heavy hydrogen; halogen; A nitrile group; A substituted or unsubstituted monocyclic or polycyclic cycloalkyl group having 3 to 30 carbon atoms; A substituted or unsubstituted, straight or branched chain alkyl group having 1 to 30 carbon atoms; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; And a substituted or unsubstituted monocyclic or polycyclic heteroaryl group having 2 to 30 carbon atoms.

In the present specification, the phosphine oxide group specifically includes a diphenylphosphine oxide group, dinaphthylphosphine oxide, and the like, but is not limited thereto.

In the present specification, the aryl group is not particularly limited, but preferably has 6 to 30 carbon atoms, and the aryl group may be monocyclic or polycyclic.

When the aryl group is a monocyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 6 to 30 carbon atoms. Specific examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group, and the like, but are not limited thereto.

When the aryl group is a polycyclic aryl group, the number of carbon atoms is not particularly limited. And preferably 10 to 30 carbon atoms. Specific examples of the polycyclic aryl group include naphthyl, anthracenyl, phenanthryl, pyrenyl, perylenyl, klychenyl, fluorenyl, and the like.

In the present specification, the fluorenyl group may be substituted, and adjacent substituents may be bonded to each other to form a ring.

,

,

및

등이 될 수 있다. 다만, 이에 한정되는 것은 아니다.When the fluorenyl group is substituted,

,

,

And

And the like. However, the present invention is not limited thereto.

In the present specification, the aryl group in the aryloxy group, the arylthioxy group, the arylsulfoxy group, the N-arylalkylamine group, the N-arylheteroarylamine group and the arylphosphine group is the same as the aforementioned aryl group. Specific examples of the aryloxy group include a phenoxy group, a p-tolyloxy group, a m-tolyloxy group, a 3,5-dimethyl-phenoxy group, a 2,4,6- trimethylphenoxy group, a p- Naphthyloxy group, 4-methyl-1-naphthyloxy group, 5-methyl-2-naphthyloxy group, 1-anthryloxy group , 2-anthryloxy group, 9-anthryloxy group, 1-phenanthryloxy group, 3-phenanthryloxy group and 9-phenanthryloxy group and the arylthioxy group includes phenylthio group, 2- Methylphenylthio group, 4-tert-butylphenylthio group and the like, and examples of the arylsulfoxy group include a benzene sulfoxide group and a p-toluenesulfoxy group. However, the present invention is not limited thereto.

In the present specification, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group having at least two aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or a monocyclic aryl group and a polycyclic aryl group at the same time. For example, the aryl group in the arylamine group may be selected from the examples of the aryl group described above.

In the present specification, the heteroaryl group includes at least one non-carbon atom and at least one hetero atom. Specifically, the hetero atom may include one or more atoms selected from the group consisting of O, N, Se and S, and the like. The number of carbon atoms is not particularly limited, but is preferably 2 to 30 carbon atoms, and the heteroaryl group may be monocyclic or polycyclic. Examples of the heterocyclic group include a thiophene group, a furanyl group, a pyrrolyl group, an imidazolyl group, a thiazolyl group, an oxazolyl group, an oxadiazolyl group, a pyridyl group, a bipyridyl group, a pyrimidyl group, A substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic group, , An isoquinolinyl group, an indolyl group, a carbazolyl group, a benzoxazolyl group, a benzimidazolyl group, a benzothiazolyl group, a benzocarbazolyl group, a benzothiophene group, a dibenzothiophene group, a benzofuranyl group, But are not limited to, phenanthroline, thiazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, benzothiazolyl, phenothiazyl and dibenzofuranyl groups.

In the present specification, examples of the heteroarylamine group include a substituted or unsubstituted monoheteroarylamine group, a substituted or unsubstituted diheteroarylamine group, or a substituted or unsubstituted triheteroarylamine group. The heteroarylamine group having two or more heteroaryl groups may include a monocyclic heteroaryl group, a polycyclic heteroaryl group, or a monocyclic heteroaryl group and a polycyclic heteroaryl group at the same time. For example, the heteroaryl group in the heteroarylamine group may be selected from the examples of the above-mentioned heteroaryl group.

In the present specification, examples of the heteroaryl group in the N-arylheteroarylamine group and the N-alkylheteroarylamine group are the same as the examples of the above-mentioned heteroaryl group.

In the present specification, the heterocyclic group may be monocyclic or polycyclic, and may be an aromatic, aliphatic or aromatic and aliphatic condensed ring, and examples thereof may be selected from the above heteroaryl groups.

In the present specification, an arylene group means a divalent group having two bonding positions in an aryl group. The description of the aryl group described above can be applied except that each of these is 2 groups.

In the present specification, the heteroarylene group means that the heteroaryl group has two bonding positions, that is, divalent. The description of the above-mentioned heteroaryl groups can be applied, except that they are each 2 groups.

According to one embodiment of the present invention, the heterocyclic compound represented by the formula (1) may be represented by any one of the following formulas (2) to (4).

(2)

(3)

[Chemical Formula 4]

In the above formulas 2 to 4,

Ar ₁ to Ar ₃ , L ₁ , L ₂ and n are the same as defined in the above formula (1).

According to one embodiment of the present invention, Ar ₁ and Ar ₂ are the same or different from each other, and each independently represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic group Or an aryl group having 6 to 30 carbon atoms, which is substituted or unsubstituted with one or more substituents selected from the group consisting of

According to another embodiment of the present invention, Ar ₁ and Ar ₂ are the same or different from each other and each independently substituted with one or two or more substituents selected from the group consisting of deuterium, an alkyl group, an aryl group and a heterocyclic group Or an unsubstituted aryl group having 6 to 30 carbon atoms.

According to another embodiment of the present invention, Ar ₁ and Ar ₂ are the same or different and are each independently a substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl; A substituted or unsubstituted naphthyl group; And a substituted or unsubstituted fluorenyl group.

According to another embodiment of the present invention, Ar ₁ and Ar ₂ are the same or different and are each independently a phenyl group substituted or unsubstituted with an alkyl group; A biphenyl group; Naphthyl group; Or a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group.

According to another embodiment of the present invention, Ar ₁ and Ar ₂ are the same or different from each other and are each independently a phenyl group; A phenyl group substituted with a methyl group; a phenyl group substituted with a t-butyl group; A biphenyl group; Naphthyl group; A methyl group or a fluorenyl group substituted or unsubstituted with a phenyl group.

According to one embodiment of the present invention, Ar ₃ is one or two or more substituents selected from the group consisting of deuterium, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic group Substituted or unsubstituted C2-C30 heteroaryl group.

According to another embodiment of the present invention, Ar ₃ is a heteroaryl group having 2 to 30 carbon atoms which is substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, alkyl group, aryl group and heterocyclic group to be.

According to another embodiment of the present invention, Ar ₃ is a substituted or unsubstituted carbazolyl group; A substituted or unsubstituted benzocarbazolyl group; A substituted or unsubstituted quinolyl group; A substituted or unsubstituted dibenzothiophene group; A substituted or unsubstituted dibenzofurane group; A substituted or unsubstituted pyrimidyl; A substituted or unsubstituted pyridyl group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted thienothiophene group; A substituted or unsubstituted benzoquinolyl group; A substituted or unsubstituted phenanthrolinyl group; A substituted or unsubstituted isoquinolyl group; A substituted or unsubstituted pyrrolyl group; A substituted or unsubstituted furan group; A substituted or unsubstituted pyridazinyl group; A substituted or unsubstituted phthalazinyl group; A substituted or unsubstituted triazolyl group; A substituted or unsubstituted oxadiazolyl group; A substituted or unsubstituted thiadiazolyl group; A substituted or unsubstituted quinazolinyl group; Or a substituted or unsubstituted 4-or 5-membered heteroarylene group containing N as a hetero atom.

According to another embodiment of the present invention, Ar ₃ is a carbazolyl group substituted or unsubstituted with an aryl group; Benzocarbazolyl group; A quinolyl group substituted or unsubstituted with a heteroaryl group; A dibenzothiophene group; A dibenzofurane group; A pyrimidyl group substituted or unsubstituted with an aryl group; A pyridyl group substituted or unsubstituted with a heteroaryl group; Thiophene group; Thienothiophenyl group; Benzoquinolyl group, phenanthrolinyl group; An isoquinolyl group; A pyrrolyl group; Furan group; A pyridazinyl group substituted or unsubstituted with an aryl group; A phthalazinyl group substituted or unsubstituted with an aryl group; Triazolyl group; An oxadiazolyl group substituted or unsubstituted with an aryl group; A thiadiazolyl group substituted or unsubstituted with an aryl group; A quinazolinyl group substituted or unsubstituted with an aryl group; Or a heteroatom containing N and is a tetra- or pentacoarylheteroaryl group.

According to another embodiment of the present invention, Ar ₃ is a carbazolyl group substituted or unsubstituted with a phenyl group or a naphthyl group; Benzocarbazolyl group; A quinolyl group substituted or unsubstituted with a pyridyl group; A dibenzothiophene group; A dibenzofurane group; A pyrimidyl group substituted or unsubstituted with one or two substituents selected from the group consisting of a phenyl group and a naphthyl group; A pyridyl group substituted or unsubstituted with a pyridyl group; Thiophene group; Thienothiophenyl group; Benzoquinolyl group, phenanthrolinyl group; An isoquinolyl group; A pyrrolyl group; Furan group; A pyridazinyl group substituted or unsubstituted with a phenyl group; A phthalazinyl group substituted or unsubstituted with a phenyl group; Triazolyl group; An oxadiazolyl group substituted or unsubstituted with a phenyl group; A thiadiazolyl group substituted or unsubstituted with a phenyl group; A quinazolinyl group substituted or unsubstituted with a phenyl group or a biphenyl group; Or a 4-or 5-membered heteroaryl group containing N as a heteroatom.

The heteroaryl group having 4 hetero rings including N as the hetero atom may be represented by the following structure, but is not limited thereto.

The 5-membered heteroaryl group containing N as the heteroatom may be represented by the following structure, but is not limited thereto.

는 화학식 1의 L₂를 통하여 화학식 1에 연결되는 부위이다.In the above structure,

Is a moiety connected to formula (1) via L < ₂ > in formula (1).

According to one embodiment of the present invention, L ₁ and L ₂ are the same or different from each other and are each independently a direct bond; An arylene group having 6 to 30 carbon atoms, which is substituted or unsubstituted with one or more substituents selected from the group consisting of a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic group; Or a heteroaryl group having 2 to 30 carbon atoms which is substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic group Lt; / RTI >

According to another embodiment of the present invention, L ₁ and L ₂ are the same or different and are each independently a direct bond; An arylene group having 6 to 30 carbon atoms which is substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, an alkyl group, an aryl group and a heterocyclic group; Or a heteroarylene group having 2 to 30 carbon atoms which is substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium, an alkyl group, an aryl group and a heterocyclic group.

According to another embodiment of the present invention, L ₁ and L ₂ are the same or different and are each independently a direct bond; A phenylene group; Biphenyllylene groups; Naphthylene group; Phenanthrenylene group; A divalent thiophene group; A bivalent furan group; A fluorenylene group substituted or unsubstituted with an alkyl group or an aryl group; A spirobifluorenylene group; A phenylene group-fluorenylene group-phenylene group; A divalent dibenzofurane group; A divalent dibenzothiophene group; A carbazolylene group substituted or unsubstituted with an aryl group; A divalent benzonaphthofuran group; A pyridazinylene group; Phthalazylene group; Or a thiadiazolylene group.

According to another embodiment of the present invention, L ₁ and L ₂ are the same or different and are each independently a direct bond; A phenylene group; Biphenyllylene groups; Naphthylene group; Phenanthrenylene group; A divalent thiophene group; A bivalent furan group; A fluorenylene group substituted or unsubstituted with a methyl group or a phenyl group; A spirobifluorenylene group; A phenylene group-fluorenylene group-phenylene group; A divalent dibenzofurane group; A divalent dibenzothiophene group; A carbazolylene group substituted or unsubstituted with a phenyl group; A divalent benzonaphthofuran group; A pyridazinyl group; Phthalazylene group; Or a thiadiazolylene group.

The phenylene group-fluorenylene group-phenylene group may have the following structure, but is not limited thereto.

는 화학식 1 및 Ar₃에 연결되는 부위이다.In the above structure,

Is a moiety connected to the formula (1) and Ar ₃ .

According to an embodiment of the present invention, when n is 2 in the formula 1, two Ar _{3 s} are the same or different from each other, and the two Ar _{3 s} are Ar ₃ and Ar ' ₃ , respectively, ₃ is the same as the definition of Ar ₃ above.

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 1 below.

[Table 1]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 2 below.

[Table 2]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 3 below.

[Table 3]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 4 below.

[Table 4]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 5 below.

[Table 5]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 6 below.

[Table 6]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 7 below.

[Table 7]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 8 below.

[Table 8]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 9 below.

[Table 9]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 10 below.

[Table 10]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 11 below.

[Table 11]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 12 below.

[Table 12]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 13 below.

[Table 13]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 14 below.

[Table 14]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 15 below.

[Table 15]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 16 below.

[Table 16]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 17 below.

[Table 17]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 18 below.

[Table 18]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 19 below.

[Table 19]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 20 below.

[Table 20]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 21 below.

[Table 21]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 22 below.

[Table 22]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 23 below.

[Table 23]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 24 below.

[Table 24]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 25 below.

[Table 25]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 26 below.

[Table 26]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 27 below.

[Table 27]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 28 below.

[Table 28]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 29 below.

[Table 29]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 30 below.

[Table 30]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 31 below.

[Table 31]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 32 below.

[Table 32]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 33 below.

[Table 33]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 34 below.

[Table 34]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 35 below.

[Table 35]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 6 below.

[Table 36]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 7 below.

[Table 37]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 38 below.

[Table 38]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 39 below.

[Table 39]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 40 below.

[Table 40]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 41 below.

[Table 41]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 42 below.

[Table 42]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 43 below.

[Table 43]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 44 below.

[Table 44]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 45 below.

[Table 45]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 46 below.

[Table 46]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 7 below.

[Table 47]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 48 below.

[Table 48]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 9 below.

[Table 49]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 50 below.

[Table 50]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 51 below.

[Table 51]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 52 below.

[Table 52]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 53 below.

[Table 53]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 54 below.

[Table 54]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 55 below.

[Table 55]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 56 below.

[Table 56]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 57 below.

[Table 57]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 58 below.

[Table 58]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 59 below.

[Table 59]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 60 below.

[Table 60]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 61 below.

[Table 61]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 62 below.

[Table 62]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 63 below.

[Table 63]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 64 below.

[Table 64]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 65 below.

[Table 65]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 66 below.

[Table 66]

According to one embodiment of the present disclosure, the heterocyclic compound of Formula 1 is selected from the compounds of Table 67 below.

[Table 67]

According to an embodiment of the present invention, there is provided an organic light emitting device comprising the heterocyclic compound represented by Formula 1.

According to one embodiment of the present disclosure, there is provided a liquid crystal display comprising: a first electrode; A second electrode facing the first electrode; And at least one organic compound layer disposed between the first electrode and the second electrode, wherein at least one of the organic compound layers includes a heterocyclic compound represented by Formula 1 An organic light emitting device is provided.

The organic material layer of the organic light emitting device of the present invention may have a single layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, the organic light emitting device of the present invention may have a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer as an organic material layer. However, the structure of the organic light emitting device is not limited thereto and may include fewer or more organic layers.

According to another embodiment of the present invention, the organic layer includes a light emitting layer, and the light emitting layer includes the heterocyclic compound represented by Formula 1 as a host of the light emitting layer.

According to an embodiment of the present invention, the organic material layer includes an electron transport layer or an electron injection layer, and the electron transport layer or the electron injection layer includes the heterocyclic compound represented by the formula (1).

According to one embodiment of the present invention, the electron transporting layer, the electron injecting layer, or the layer which simultaneously transports electrons and injects electrons includes the heterocyclic compound represented by the above formula (1).

According to one embodiment of the present invention, the organic material layer may include a hole injection layer or a hole transport layer containing a compound having an arylamino group, a carbazole group or a benzocarbazole group in addition to an organic material layer containing a heterocyclic compound represented by the formula .

According to one embodiment of the present invention, the organic material layer containing the heterocyclic compound represented by the general formula (1) includes the heterocyclic compound represented by the general formula (1) as a host and other organic compound, metal or metal compound as a dopant do.

According to another embodiment of the present invention, the organic light emitting device may be a normal type organic light emitting device in which an anode, one or more organic compound layers, and a cathode are sequentially stacked on a substrate.

According to another embodiment of the present invention, the organic light emitting device may be an inverted type organic light emitting device in which a cathode, at least one organic layer, and an anode are sequentially stacked on a substrate.

For example, the structure of the organic light emitting device according to one embodiment of the present disclosure is illustrated in FIGS.

1, the structure of an organic electronic device in which a substrate 20, an anode 30, a light emitting layer 40, and a cathode 50 are sequentially stacked is illustrated. In this structure, the heterocyclic compound represented by Formula 1 may be included in the light emitting layer 40.

2, the organic light emitting device 11 includes a substrate 20, an anode 30, a hole injection layer 60, a hole transport layer 70, a light emitting layer 40, an electron transport layer 80, an electron injection layer 90, And a cathode 50 are successively laminated on a substrate 50. The organic electroluminescent device shown in FIG. In this structure, the heterocyclic compound represented by Formula 1 may be at least one of the hole injection layer 60, the hole transport layer 70, the light emitting layer 40, the electron transport layer 80, and the electron injection layer 90 .

In such a structure, the heterocyclic compound represented by Formula 1 may be included in one or more layers of the hole injection layer, the hole transport layer, the light emitting layer, the electron transport layer, and the electron injection layer.

The organic light emitting device of the present invention is manufactured by materials and methods known in the art except that one or more of the organic layers include the heterocyclic compound of the present specification, that is, the heterocyclic compound represented by the above formula (1) .

When the organic light emitting diode includes a plurality of organic layers, the organic layers may be formed of the same material or different materials.

The organic light emitting device of the present invention may be formed by a material and a method known in the art except that at least one layer of the organic material layer contains a heterocyclic compound represented by the formula 1, that is, a heterocyclic compound represented by the formula 1 .

For example, the organic light emitting device of the present invention can be manufactured by sequentially laminating a first electrode, an organic material layer, and a second electrode on a substrate. At this time, a metal or a metal oxide having conductivity or an alloy thereof is deposited on the substrate using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation Forming a first electrode, forming an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, and an electron transporting layer on the first electrode, and depositing a material usable as a second electrode thereon. In addition to such a method, an organic light emitting device can be formed by sequentially depositing a second electrode material, an organic material layer, and a first electrode material on a substrate.

In addition, the compound of Formula 1 may be formed into an organic material layer by a solution coating method as well as a vacuum evaporation method in the production of an organic light emitting device. Here, the solution coating method refers to spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating and the like, but is not limited thereto.

According to one embodiment of the present invention, the first electrode is an anode and the second electrode is a cathode.

According to another embodiment of the present invention, the first electrode is a cathode and the second electrode is a cathode.

As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO _2: a combination of a metal and an oxide such as Sb; Conductive polymers such as poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDOT), polypyrrole and polyaniline.

The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or alloys thereof; Layer structure materials such as LiF / Al or LiO ₂ / Al, but are not limited thereto.

The hole injecting layer is a layer for injecting holes from the electrode as a hole injecting material and a hole injecting effect for injecting holes in the anode as a hole injecting material and an excellent hole injecting effect for a light emitting layer or a light emitting material , The migration of excitons generated in the light emitting layer to the electron injection layer or the electron injection material, and also the ability to form thin films is preferable. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrin, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene- , Anthraquinone, polyaniline and polythiophene-based conductive polymers, but the present invention is not limited thereto.

The hole transport layer is a layer that transports holes from the hole injection layer to the light emitting layer. The hole transport material is a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer. The material is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.

The light emitting material of the light emitting layer is preferably a material capable of emitting light in the visible light region by transporting and receiving holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having high quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq ₃ ); Carbazole-based compounds; Dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; Benzoxazole, benzothiazole and benzimidazole compounds; Polymers of poly (p-phenylenevinylene) (PPV) series; Spiro compounds; Polyfluorene, rubrene, and the like, but are not limited thereto.

The light emitting layer may include a host material and a dopant material. The host material may be a condensed aromatic ring derivative or a heterocyclic compound. Specific examples of the condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds. Examples of the heterocyclic compound include carbazole derivatives, dibenzofuran derivatives, Furan compounds, pyrimidine derivatives, and the like, but are not limited thereto.

Examples of the dopant material include aromatic amine derivatives, styrylamine compounds, boron complexes, fluoranthene compounds, and metal complexes. Specific examples of the aromatic amine derivatives include condensed aromatic ring derivatives having substituted or unsubstituted arylamino groups, and examples thereof include pyrene, anthracene, chrysene, and peripherrhene having an arylamino group. Examples of the styrylamine compound include substituted or unsubstituted Wherein at least one aryl vinyl group is substituted with at least one aryl vinyl group, and at least one substituent selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group and an arylamino group is substituted or unsubstituted. Specific examples thereof include, but are not limited to, styrylamine, styryldiamine, styryltriamine, styryltetraamine, and the like. Examples of the metal complex include iridium complex, platinum complex, and the like, but are not limited thereto.

The electron transporting material of the electron transporting layer is a layer that transports electrons from the electron injecting layer to the electron transporting layer and transports electrons from the cathode to the light emitting layer. This large material is suitable. Specific examples include an Al complex of 8-hydroxyquinoline; Complexes containing Alq ₃ ; Organic radical compounds; Hydroxyflavone-metal complexes, and the like, but are not limited thereto. The electron transporting layer can be used with any desired cathode material as used according to the prior art. In particular, an example of a suitable cathode material is a conventional material having a low work function followed by an aluminum layer or a silver layer. Specifically cesium, barium, calcium, ytterbium and samarium, in each case followed by an aluminum layer or a silver layer.

The electron injection layer is a layer for injecting electrons from the electrode. The electron injection layer has the ability to transport electrons, has an electron injection effect from the cathode, and has an excellent electron injection effect with respect to the light emitting layer or the light emitting material. A compound which prevents migration to a layer and is excellent in a thin film forming ability is preferable. Specific examples thereof include fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylene tetracarboxylic acid, preorenylidene methane, A complex compound and a nitrogen-containing five-membered ring derivative, but are not limited thereto.

Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis (8-hydroxyquinolinato) zinc, bis (8-hydroxyquinolinato) copper, bis (8- Tris (8-hydroxyquinolinato) aluminum, tris (2-methyl-8-hydroxyquinolinato) aluminum, tris (8- hydroxyquinolinato) gallium, bis (10- Quinolinato) beryllium, bis (10-hydroxybenzo [h] quinolinato) zinc, bis (2-methyl-8- quinolinato) chlorogallium, bis (2-methyl-8-quinolinato) (2-naphtholato) gallium, and the like, But is not limited thereto.

The organic light emitting device according to the present invention may be of a top emission type, a back emission type, or a both-side emission type, depending on the material used.

According to one embodiment of the present invention, the heterocyclic compound represented by Formula 1 may be included in an organic solar cell or an organic transistor in addition to an organic light emitting device.

Hereinafter, the present invention will be described in detail by way of examples with reference to the drawings. However, the embodiments according to the present disclosure can be modified in various other forms, and the scope of the present specification is not construed as being limited to the embodiments described below. Embodiments of the present disclosure are provided to more fully describe the present disclosure to those of ordinary skill in the art.

Synthesis Example 1-1 Synthesis of Intermediate 1-A

3-bromo-5-chlorobenzaldehyde (30 g, 136.7 mmol), Benzamidine Hydrochloride (42.8 g, 273.4 mmol) and K ₃ PO ₄ (58.0 g, 273.4 mmol) were placed in dimethylsulfoxide (DMSO) ≪ / RTI > for 1 hour. After the reaction was completed, water was added to the reaction mixture to form a solid, which was filtered to give a pale yellow solid. This insert the tetrahydrofuran was dissolved again in (THF) into the MgSO ₄ dried after 2,3-dichloro-5,6-dicyano- p-benzoquinone (DDQ) (37.9 g, 136.7 mmol) was stirred for 10 minutes at room temperature. After completion of the reaction, the reaction mixture was filtered, and the resulting solution was distilled under reduced pressure. The crude product was purified by column chromatography on silica gel using 0-10% ethyl acetate in hexane as the eluent to give off-white solid (50.3 g, 87% yield; MS: [M + H] ⁺ = 422 ).

Synthesis Example 1-2 Synthesis of Intermediate 1-B

Intermediate 1-A (50 g, 118.3 mmol), (4- (pyridin-2-yl) phenyl) boronic acid (23.5 g, 118.3 mmol), K 2 CO 3 (49.1 g, 354.9 mmol), Pd (PPh 3 ) ₄ (2.7 g, 2 mol%) were placed in a round bottom flask, and tetrahydrofuran (THF) (500 ml) and H 2 O (250 ml) were poured and the mixture was refluxed for 3 hours. After the completion of the reaction remove the water layer and the organic layer was evaporated under reduced pressure after dried over Mg SO _{4 3.} The crude product was dissolved in CHCl ₃ and recrystallized using ethyl acetate as an anti-solvent to obtain Intermediate 1-B (53 g, yield 91%; MS: [M + H] ⁺ = 497).

Synthesis Example 1-3 Synthesis of Intermediate 1-C

(31.4 g, 319.8 mmol), Pd (dba) ₂ (1.84 g, 3 mol%), PCy ₃ (1.79 g, 6 mol%) was placed in dioxane (500 ml) and refluxed for 12 hours. After the reaction was completed, the mixture was cooled to room temperature and the mixture was filtered to remove the salt. The resulting liquid was distilled under reduced pressure to obtain a dark brown solid. This was dissolved in CHCl ₃ , dissolved in CHCl ₃ , and recrystallized using ethyl acetate as an anti-solvent to obtain Intermediate 1-C (51.4 g, yield 82%; MS: [M + H] ⁺ = 589).

Synthesis Example 2-1 Synthesis of Intermediate 2-B

The procedure of Synthesis Example 1-2 was repeated except that 3- (pyridin-2-yl) phenyl) boronic acid (23.5 g, 118.3 mmol) was used instead of 4- (pyridin- 2-B (49.6 g, yield 84%; MS: [M + H] ⁺ = 497) was obtained in the same manner as in 2).

Synthesis Example 2-2 Synthesis of Intermediate 2-C

Intermediate 2-C (47.6 g, yield 81%; MS: [M + H] +) was obtained in the same manner as in Synthetic Example 1-3 except that Intermediate 2-B (49.6 g, 99.8 mmol) M + H] < ⁺ > = 589).

Synthesis Example 1 Synthesis of Compound 1-1

Intermediate 1-C (13 g, 22.1 mmol), 9- (4-bromophenyl) -9H-carbazole (7.12 g, 22.1 mmol), Pd (PPh 3) 4 (0.76 g, 3 mol%), K 2 CO 3 (6.11 g, 44.2 mmol) was added to tetrahydrofuran (THF) (110 ml) and H ₂ O (55 ml) and refluxed for 12 hours. After the reaction was completed, the reaction mixture was cooled to room temperature and the precipitated solid was filtered. The resulting solid was dissolved in CHCl ₃ , dried over MgSO ₄ , filtered through a pad of celite, and recrystallized by adding EtOH to the filtrate. The resulting crystals were filtered and dissolved in tetrahydrofuran (THF), followed by recrystallization with EA to obtain Compound 1-1 (9.6 g, yield 62%; MS: [M + H] ⁺ = 704).

Synthesis Example 2 Synthesis of Compound 1-4

In the same manner as in Synthesis Example 1, except that 7- (4-bromophenyl) -7H-benzo [c] carbazole (8.23 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 1-4 (11.4 g, yield 68%; MS: [M + H] < ⁺ > = 754).

Synthesis Example 3 Synthesis of Compound 1-7

In the same manner as in Synthesis Example 1, except that 3- (4-bromophenyl) -9-phenyl-9H-carbazole (8.8 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) 1-7 (7.6 g, yield 44%; MS: [M + H] < ⁺ > = 780).

Synthesis Example 4 Synthesis of Compound 1-9

In the same manner as in Synthesis Example 1, except that 8- (4-bromophenyl) quinoline (6.28 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- Yield: 75%; MS: [M + H] < ⁺ > = 666).

Synthesis Example 5 Synthesis of Compound 1-16

In the same manner as in Synthesis Example 1, except that 4- (4-bromophenyl) dibenzo [b, d] thiophene (7.50 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- -16 (10.3 g, yield 65%; MS: [M + H] < ⁺ > = 721).

Synthesis Example 6 Synthesis of Compound 1-20

In the same manner as in Synthesis Example 1 except that 4- (4-bromophenyl) dibenzo [b, d] furan (7.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- -20 (9.8 g, yield 63%; MS: [M + H] ⁺ = 705).

Synthesis Example 7 Synthesis of Compound 1-24

In the same manner as in Synthesis Example 1 except for using 4- (4-bromophenyl) -2,6-diphenylpyrimidine (8.6 g, 22.1 mmol) instead of 9- (4-bromophenyl) -9H- 24 (13.8 g, yield 81%; MS: [M + H] < ⁺ > = 769).

Synthesis Example 8 Synthesis of Compound 1-25

In the same manner as in Synthesis Example 1 except that 2- (4-bromophenyl) -4,6-diphenylpyrimidine (8.6 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 25 (12.4 g, yield 73%; MS: [M + H] < ⁺ > = 769).

Synthesis Example 9 Synthesis of Compound 1-27

Except that 4 '- (4-bromophenyl) -2,2': 6 ', 2 "-terpyridine (8.6 g, 22.1 mmol) was used in place of 9- (4-bromophenyl) -9H- (13.0 g, yield 76%; MS: [M + H] < ⁺ > = 770) was obtained in the same manner as in Example 1.

Synthesis Example 10 Synthesis of Compound 1-30

In the same manner as in Synthesis Example 1, except that 6- (4-bromophenyl) phenanthridine (66.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- Yield: 68%; MS: [M + H] < ⁺ > = 716).

Synthesis Example 11 Synthesis of Compound 1-42

In the same manner as in Synthesis Example 1 except that 5- (4-bromophenyl) -1,10-phenanthroline (7.4 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 42 (10.2 g, yield 64%; MS: [M + H] ⁺ = 717).

Synthesis Example 12 Synthesis of Compound 1-61

In the same manner as in Synthesis Example 1, except that 3- (4-bromophenyl) -6-phenylpyridazine (6.9 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 8.9 g, yield 58%; MS: [M + H] < ⁺ > = 693).

Synthesis Example 13 Synthesis of Compound 1-77

In the same manner as in Synthesis Example 1, except that 2- (4-bromophenyl) -4-phenylquinazoline (8.0 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 9.4 g, yield 57%; MS: [M + H] < ⁺ > = 743).

Synthesis Example 14 Synthesis of Compound 2-1

In the same manner as in Synthesis Example 1, except that 9- (3-bromophenyl) -9H-carbazole (7.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) 12.1 g, yield 78%; MS: [M + H] < ⁺ > = 704).

Synthesis Example 15 Synthesis of Compound 2-7

Except that 3- (3-bromophenyl) -9-phenyl-9H-carbazole (8.8 g, 22.1 mmol) was used in place of 9- (4-bromophenyl) -9H-carbazole in Synthesis Example 1 2-7 (12.9 g, yield 75%; MS: [M + H] < ⁺ > = 780).

Synthesis Example 16 Synthesis of Compound 2-9

(10.7 g, 22.1 mmol) was obtained in the same manner as in Synthesis Example 1, except that 8- (3-bromophenyl) quinoline (6.3 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) Yield: 73%; MS: [M + H] < ⁺ > = 666).

Synthesis Example 17 Synthesis of Compound 2-24

The same procedure as in Synthesis Example 1 was carried out except that 4- (3-bromophenyl) -2,6-diphenylpyrimidine (8.6 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 24 (10.9 g, yield 64%; MS: [M + H] < ⁺ > = 769).

Synthesis Example 18 Synthesis of Compound 2-25

Except that 2- (3-bromophenyl) -4,6-diphenylpyrimidine (8.6 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H-carbazole in Synthesis Example 1, 25 (9.6 g, yield 56%; MS: [M + H] < ⁺ > = 769).

Synthesis Example 19 Synthesis of Compound 3-1

In the same manner as in Synthesis Example 1, except that 9- (2-bromophenyl) -9H-carbazole (7.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) 8.9 g, yield 57%; MS: [M + H] < ⁺ > = 704).

Synthesis Example 20 Synthesis of Compound 3-9

In the same manner as in Synthesis Example 1, except that 8- (2-bromophenyl) quinoline (6.3 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- Yield: 69%; MS: [M + H] < ⁺ > = 666).

Synthesis Example 21 Synthesis of Compound 3-10

(9.7 g, 22.1 mmol) was obtained in the same manner as in Synthesis Example 1 except that 7- (2-bromophenyl) quinoline (6.3 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) Yield: 66%; MS: [M + H] < ⁺ > = 666).

Synthesis Example 22 Synthesis of Compound 3-12

Compound (3-10) (6.5 g, 22.1 mmol) was obtained in the same manner as in Synthesis Example 1, except that 5- (2-bromophenyl) quinoline (6.3 g, 22.1 mmol) was used in place of 9- (4-bromophenyl) Yield: 44%; MS: [M + H] < ⁺ > = 666).

Synthesis Example 23 Synthesis of Compound 3-16

In the same manner as in Synthesis Example 1 except that 4- (2-bromophenyl) dibenzo [b, d] thiophene (7.5 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- -16 (8.4 g, yield 53%; MS: [M + H] ⁺ = 721).

Synthesis Example 24 Synthesis of Compound 3-42

In the same manner as in Synthesis Example 1 except for using 5- (2-bromophenyl) -1,10-phenanthroline (7.4 g, 22.1 mmol) instead of 9- (4-bromophenyl) -9H- 42 (5.2 g, yield 33%; MS: [M + H] < ⁺ > = 717).

Synthesis Example 25 Synthesis of Compound 3-44

In the same manner as in Synthesis Example 1, except that 3- (2-bromophenyl) -1,10-phenanthroline (7.4 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 44 (4.9 g, yield 31%; MS: [M + H] < ⁺ > = 717).

Synthesis Example 26 Synthesis of Compound 4-1

Intermediate 1-B (15.0 g, 30.2 mmol), 9-H-carbazole (5.0 g, 30.2 mmol), Pd (P-tBu 3) 2 (0.03 g, 0.2 mol%), Sodium tert-butixide (5.8 g, 60.4 mmol) was added to toluene (150 ml) and refluxed for 6 hours. After the reaction was completed, the mixture was cooled to room temperature, extracted three times with CHCl ₃ and water, and then the organic layer was dried over MgSO _{4. The} resulting residue was dried under reduced pressure, and recrystallized from chloroform and EtOAc to obtain Compound 4-1 (12.4 g, 65%; MS: [M + H] < ⁺ > = 628).

Synthesis Example 27 Synthesis of Compound 4-5

The same procedure as in Synthesis Example 1 was carried out except that 2-bromo-9-phenyl-9H-carbazole (7.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H- 8.1 g, yield 52%; MS: [M + H] < ⁺ > = 704).

Synthesis Example 28 Synthesis of Compound 4-7

Compound 7 was synthesized in the same manner as in Synthesis Example 1 except that 3-bromo-9-phenyl-9H-carbazole (7.1 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) 8.9 g, yield 57%; MS: [M + H] < ⁺ > = 704).

Synthesis Example 29 Synthesis of Compound 4-9

Compound 4-9 (6.9 g, yield: 53%; MS (yield: 53%) was obtained in the same manner as in Synthesis Example 1, except that 8-bromoquinoline (4.6 g, 22.1 mmol) was used in place of 9- (4-bromophenyl) : [M + H] < ⁺ > = 590).

Synthesis Example 30 Synthesis of Compound 5-1

9- (4'-bromo- [1,1'-biphenyl] -4-yl) -9H-carbazole (8.8 g, 22.1 mmol) was used in place of 9- (4-bromophenyl) -9H- (Yield: 56%; MS: [M + H] < ⁺ > = 780) was obtained in the same manner as in Synthesis Example 1. [

Synthesis Example 31 Synthesis of Compound 13-1

(8.2 g, yield 53%; MS: [M + H]) was obtained in the same manner as in Synthesis Example 1, except that Intermediate 2-C (13 g, 22.1 mmol) ⁺ = 704).

Synthesis Example 32 Synthesis of Compound 13-2

(4-bromophenyl) -11H-benzo [c] thiophene instead of 9- (4-bromophenyl) -9H-carbazole was obtained in the same manner as in Synthesis Example 1 except that Intermediate 2-C (13 g, 22.1 mmol) (7.6 g, yield 46%; MS: [M + H] < ⁺ > = 754) was obtained in the same manner as in Synthesis Example 1, except that carbazole (8.2 g, 22.1 mmol)

Synthesis Example 33 Synthesis of Compound 13-4

7- (4-bromophenyl) -7H-benzo [c] pyridine instead of 9- (4-bromophenyl) -9H-carbazole by using Intermediate 2-C (13 g, 22.1 mmol) Compound 13-4 (8.1 g, yield 49%; MS: [M + H] ⁺ = 754) was obtained in the same manner as in Synthesis Example 1, except that carbazole (8.2 g, 22.1 mmol)

Synthesis Example 34 Synthesis of Compound 13-16

Bromodibenzo [b, d] thiophene (5.8 g, 22.1 mmol) instead of 9- (4-bromophenyl) -9H-carbazole was obtained in the same manner as Intermediate 1-C, (9.4 g, yield 59%; MS: [M + H] < ⁺ > = 721) was obtained in the same manner as in Synthesis Example 1,

Synthesis Example 35 Synthesis of Compound 13-17

3-bromodibenzo [b, d] thiophene (5.8 g, 22.1 mmol) was used instead of 9- (4-bromophenyl) -9H-carbazole by using Intermediate 2-C (13 g, 22.1 mmol) (MS: [M + H] < ⁺ > = 721) was obtained in the same manner as in Synthesis Example 1,

Synthesis Example 36 Synthesis of Compound 13-18

Bromodibenzo [b, d] thiophene (5.8 g, 22.1 mmol) instead of 9- (4-bromophenyl) -9H-carbazole was obtained in the same manner as Intermediate 1-C, (9.3 g, yield 58%; MS: [M + H] < ⁺ > = 721) was obtained in the same manner as in Synthesis Example 1,

[Example 1]

A glass substrate coated with ITO (indium tin oxide) having a thickness of 500 Å was immersed in distilled water containing detergent and washed with ultrasonic waves. At this time, Fischer Co. product was used as a detergent, and distilled water filtered by a filter of Millipore Co. was used as distilled water. The ITO was washed for 30 minutes and then washed twice with distilled water and ultrasonically cleaned for 10 minutes. After the distilled water was washed, it was ultrasonically washed with a solvent of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner. Further, the substrate was cleaned using oxygen plasma for 5 minutes, and then the substrate was transported by a vacuum evaporator.

The following compound [HI-A] was thermally vacuum deposited on the ITO transparent electrode prepared above to a thickness of 600 Å to form a hole injection layer. The compound [HAT] (50 ANGSTROM) and the following compound [HT-A] (600 ANGSTROM) were sequentially vacuum-deposited on the hole injection layer to form a hole transport layer.

Subsequently, the following compounds [BH] and [BD] were vacuum deposited on the hole transport layer at a weight ratio of 25: 1 at a thickness of 200 ANGSTROM to form a light emitting layer. Compound 1-1 and the following compound [LiQ] (Lithium quinolate) were vacuum deposited on the light emitting layer at a weight ratio of 1: 1 to form an electron injection and transport layer having a thickness of 350 Å. Lithium fluoride (LiF) and aluminum having a thickness of 1,000 Å were sequentially deposited on the electron injecting and transporting layer to form a cathode. In the above process, the deposition rate of the organic material was maintained at 0.4 to 0.9 A / sec, the deposition rate of lithium fluoride at 0.3 A / sec for aluminum and 2 A / sec at aluminum was maintained, and the degree of vacuum during deposition was 1 x 10 < by keeping the ^-7 to 5 × 10 ^-8 torr, an organic light emitting device was produced.

The driving voltage and the luminous efficiency were measured at a current density of 10 mA / cm < 2 >, and the time (T90) of 90% of the initial luminance at a current density of 20 mA / cm < 2 > was measured. The results are shown in Table 1 below.

[Examples 2 to 35]

The organic light emitting devices of Experimental Examples 2 to 35 were fabricated in the same manner as in Experimental Example 1 except that each compound shown in the following Table 68 was used in place of Compound 1-1 in Experimental Example 1.

The driving voltage and the luminous efficiency were measured at a current density of 10 mA / cm 2 in the organic light emitting device fabricated in Experimental Examples 2 to 35, and the time (T90) at 90% of the initial luminance at a current density of 20 mA / Respectively. The results are shown in Table 68 below.

[Comparative Example 1]

An organic light emitting device was fabricated in the same manner as in Example 1, except that Alq ₃ was used instead of the compound 1-1 of Example 1. The driving voltage and the luminous efficiency were measured at a current density of 10 mA / cm < 2 >, and the time (T90) of 90% of the initial luminance at a current density of 20 mA / cm < 2 > was measured. The results are shown in Table 68 below.

[Comparative Example 2]

An organic light emitting device was fabricated in the same manner as in Example 1, except that ET-A was used in place of the compound 1-1 of Example 1. The driving voltage and the luminous efficiency were measured at a current density of 10 mA / cm < 2 >, and the time (T90) of 90% of the initial luminance at a current density of 20 mA / cm < 2 > was measured. The results are shown in Table 68 below.

[Table 68]

From the results shown in Table 68, the compound represented by Formula 1 according to the present invention can be used for an organic layer capable of simultaneously injecting electrons and transporting electrons of an organic light emitting diode.

In the case of an organic light emitting device using the same, the device has a low driving voltage and a high efficiency, and the stability of the device can be improved by the hole stability of the compound. Particularly, the heterocyclic compound represented by the formula (1) according to one embodiment of the present invention has excellent thermal stability, and when used in an organic material layer capable of electron injection and electron transport at the same time, a conventionally known n-type dopant is used It is possible.

10, 11: Organic light emitting device
20: substrate
30: anode
40: light emitting layer
50: cathode
60: Hole injection layer
70: hole transport layer
80: electron transport layer
90: electron injection layer

Claims (9)

A heterocyclic compound represented by the following formula (1):
[Chemical Formula 1]

In Formula 1,
Ar ₁ and Ar ₂ are the same or different and each independently represent a substituted or unsubstituted aryl group having 6 to 30 carbon atoms,
Ar ₃ is a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms,
L ₁ and L ₂ are the same or different and are each independently a direct bond; A substituted or unsubstituted arylene group having 6 to 30 carbon atoms; Or a substituted or unsubstituted heteroarylene group having 2 to 30 carbon atoms,
n is 1 or 2,
When n is 2, Ar ₃ are the same or different from each other. The method according to claim 1,
Ar ₁ and Ar ₂ are the same or different and are each independently a substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted naphthyl group; Or a substituted or unsubstituted fluorenyl group. The method according to claim 1,
Ar ₃ is a substituted or unsubstituted carbazolyl group; A substituted or unsubstituted benzocarbazolyl group; A substituted or unsubstituted quinolyl group; A substituted or unsubstituted dibenzothiophene group; A substituted or unsubstituted dibenzofurane group; A substituted or unsubstituted pyrimidyl; A substituted or unsubstituted pyridyl group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted thienothiophene group; A substituted or unsubstituted benzoquinolyl group; A substituted or unsubstituted phenanthrolinyl group; A substituted or unsubstituted isoquinolyl group; A substituted or unsubstituted pyrrolyl group; A substituted or unsubstituted furan group; A substituted or unsubstituted pyridazinyl group; A substituted or unsubstituted phthalazinyl group; A substituted or unsubstituted triazolyl group; A substituted or unsubstituted oxadiazolyl group; A substituted or unsubstituted thiadiazolyl group; A substituted or unsubstituted quinazolinyl group; Or a heterocyclic compound containing a heteroatom N and a substituted or unsubstituted quadri- or pentafluoroaryl group. The method according to claim 1,
L ₁ and L ₂ are the same or different and are each independently a direct bond; A substituted or unsubstituted phenylene group; A substituted or unsubstituted biphenylene group; A substituted or unsubstituted naphthylene group; A substituted or unsubstituted phenanthrenylene group; A substituted or unsubstituted divalent thiophene group; A substituted or unsubstituted divalent furan group; A substituted or unsubstituted fluorenylene group; A substituted or unsubstituted spirobifluorenylene group; A substituted or unsubstituted phenylene group-fluorenylene group-phenylene group; A substituted or unsubstituted divalent dibenzofurane group; A substituted or unsubstituted divalent dibenzothiophene group; A substituted or unsubstituted carbazolylene group; A substituted or unsubstituted divalent benzonaphthofuran group; A substituted or unsubstituted pyridazinyl group; A substituted or unsubstituted phthalazylene group; Or a substituted or unsubstituted thiadiazolylene group. The method according to claim 1,
Wherein the heterocyclic compound represented by Formula 1 is represented by any one of the following Formulas 2 to 4:
(2)

(3)

[Chemical Formula 4]

In the above formulas 2 to 4,
Ar ₁ to Ar ₃ , L ₁ , L ₂ and n are the same as defined in the above formula (1). A first electrode; A second electrode facing the first electrode; And at least one organic compound layer provided between the first electrode and the second electrode,
Wherein at least one of the organic material layers comprises a heterocyclic compound according to any one of claims 1 to 5. 7. The organic light emitting device according to claim 6, wherein the organic layer includes a light emitting layer, and the light emitting layer comprises the heterocyclic compound. 7. The organic electroluminescent device according to claim 6, wherein the organic material layer comprises an electron transporting layer, an electron injecting layer, or a layer simultaneously carrying out electron transporting and electron injection, wherein the electron transporting layer, And an organic light emitting layer. 7. The organic light emitting diode according to claim 6, wherein the organic material layer further comprises one or more layers selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and an electron injection layer.

Images